Broeckelmann, Paul J. and Engert, Andreas (2015). The GHSG Approach to Treating Hodgkin's Lymphoma. Curr. Hematol. Malig. Rep., 10 (3). S. 256 - 266. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X
Full text not available from this repository.Abstract
Hodgkin's lymphoma (HL) is a relatively rare disease accounting for 15 % of all lymphoma. This disease has developed from an incurable disease to the adult malignancy with the most favorable prognosis. With current therapeutic approaches consisting of polychemo- and small-field radiotherapy, up to 80 % of all patients can be cured long term. In refractory or relapsed HL, intensified treatment including high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) is associated with progression-free survival (PFS) of 50 %. Evaluation of novel drugs in multiple relapsed or refractory cases, better treatment options for elderly patients and reducing treatment-related side effects are the main focus of current research. Recent clinical developments and future approaches in the treatment of HL will be discussed in this review.
Item Type: | Journal Article | ||||||||||||
Creators: |
|
||||||||||||
URN: | urn:nbn:de:hbz:38-394517 | ||||||||||||
DOI: | 10.1007/s11899-015-0262-5 | ||||||||||||
Journal or Publication Title: | Curr. Hematol. Malig. Rep. | ||||||||||||
Volume: | 10 | ||||||||||||
Number: | 3 | ||||||||||||
Page Range: | S. 256 - 266 | ||||||||||||
Date: | 2015 | ||||||||||||
Publisher: | CURRENT MEDICINE GROUP | ||||||||||||
Place of Publication: | PHILADELPHIA | ||||||||||||
ISSN: | 1558-822X | ||||||||||||
Language: | English | ||||||||||||
Faculty: | Unspecified | ||||||||||||
Divisions: | Unspecified | ||||||||||||
Subjects: | no entry | ||||||||||||
Uncontrolled Keywords: |
|
||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/39451 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
View Item |